-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Marker Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2015 to Q3 2024.
- Marker Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $53K, a 69.7% decline year-over-year.
- Marker Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $337K, a 84.4% decline year-over-year.
- Marker Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.58M, a 70.4% decline from 2022.
- Marker Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.34M, a 10.4% decline from 2021.
- Marker Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.96M, a 14.1% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)